EnlivenHealth Celebrates American Pharmacists Month » Learn More

EnlivenHealth Weekly Recap | March 8th, 2025

Here are the top stories from the last week:

Industry Updates

Private Equity Firm Sycamore Partners to Acquire Walgreens for $10 Billion
Sycamore partners is reportedly set to acquire Walgreens for $10 billion in a deal which could be finalized in the next few days. Walgreens would maintain its U.S. retail business while potentially selling or spinning off other parts into a publicly traded corporation. Learn more »

Wellvana Acquires CVS Health’s MSSP Business
Wellvana has acquired CVS Health’s Medicare Shared Savings Program (MSSP) business, supporting primary care providers across 40 states and serving approximately 1 million patients. Learn more »

Editorial – PBM Reform: Tackling Transparency, Pricing, and Patient Access
Policymakers and healthcare providers are advocating for reforms to improve transparency, pricing, and better access to critical therapies, sharing insights on the challenges posed by pharmacy benefit managers. Learn more »

Study Finds Rapid Dietary Effects on Brain Insulin and Obesity Risk
A study highlights that a brief period of overeating ultra-processed, high-calorie snacks can lead to liver fat accumulation and temporary disruption of brain insulin action. Learn more »

Long Grove Pharmaceuticals Joins Campaign for Drug Label Improvements
Long Grove Pharmaceuticals wishes to improve drug labeling following its sponsorship of a whitepaper by the Med Safety Board, which highlights that medication errors impact one in every 30 patients. Learn more »

Novo Nordisk Introduces NovoCare Pharmacy, Lowering Cost of All Doses of Approved Wegovy
Novo Nordisk has launched NovoCare Pharmacy, offering direct-to-patient home shipments of all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients. Learn more »

Report from CoverMyMeds Looks at Actionable Strategies to Bridge Gaps for Patients
CoverMyMeds’ 2025 Medication Access Report calls for increased collaboration and interoperability across the healthcare industry to improve patient outcomes. Learn more »

Drug Updates

Fresenius Kabi Releases Stelara Biosimilar
Global pharmaceutical company Fresenius Kabi has released a biosimilar for Stelara, a medication used for treating certain autoimmune conditions. Read more »

FDA Approves Revakinagene Taroetcel, Marking First Treatment for MacTel Type 2
The FDA has approved Revakinagene Taroretcel, the first treatment for macular telangiectasia type 2, based on successful phase 3 clinical trials. Read more »

Melatonin Supplementation Could Improve DNA Repair in Night Shift Workers
Research suggests that melatonin supplementation may enhance oxidative DNA damage repair capacity among night shift workers. Learn more »

X

Amplicare is now part of EnlivenHealth®

X

FDSRX is now part of EnlivenHealth®